This book provides an overview of the common concepts and building blocks of patent management. It addresses executives in the areas of innovation, R & D, patent and intellectual property management as well as academics and students.The authors give valuable information on the characteristics of patent and intellectual property management, based on the collaboration with companies and organizations from Europe, China, Japan, Argentina, Brazil, India, Canada and the US. A reference for managers who want to bring information technology innovation with a clear intellectual property strategy to the market. A very readable book. Thomas Landolt, Managing Director, IBM A really comprehensive, all-in book about Patents – strategy, value, management and commercialization. And not forgetting what they are for – foster innovation. Dr. Joerg Thomaier, Head of IP Bayer Group

Florian Jell empirically investigates the objectives that companies pursue with their patenting activities and presents empirical insights into how patent management is organized within industrial companies. The book concludes with a case study of how a company reacted to its competitor’s patenting – which led to a patent arms race.

Patents protecting biotechnological invention are becoming ever more important. Because biotechnology has many differences with respect to other technologies, lessons learned in other fields of technology cannot simply be transferred to adopt a suitable strategy for dealing with biotechnology inventions. In this volume, general aspects of biopatent law will be discussed. This involves questions of patentability, including ethical issues and issues of technicality, as well as questions of patent exhaustion in cases were reproducible subject matter, like cells or seeds, is protected. Moreover, active and passive patent strategies are addressed. Further, insight will be given into patent lifetime management and additional protective measures, like supplementary protection certificates and data exclusivity. Here, strategies are discussed how market exclusivity can be extended as long as possible, which is particularly important for biopharmaceutical drugs, which create high R&D costs.

The book is a coaching guide for anyone interested in intellectual property and those wanting to embark on or develop patent creation. It draws on the authors’ extensive experience and insights from change projects, management and leadership at Nokia. The book guides the reader through each stage of setting up a successful unit, inviting active involvement by asking vital questions about their needs and aims. Focusing on key issues and themes involved, it provides examples, diagrams and models to illustrate how they can be out in to practice. Critical chapters include the core activities of patent creation, possible organisational models, costs, quality and the comparison of external and internal allocation of tasks. Discussion concentrates on how to such define roles and responsibilities and the management techniques of external resources. The book encourages the reader to challenge their current organisational structure and strategy by introducing various methods and tactics that can be deployed when considering patent creation, then offering advice into the pros and cons of techniques and how such methods can be assessed. The book highlights how knowledge and innovation can be utilised and protected, which due to the increased importance of intellectual property rights, especially the use of patents, is essential for every business.

Suggests empirical justification to its arguments, both for the United States and Europe, covering two of the most important patenting institutions (EP, USPTO). Offers a composite index for measuring patent valuation and analyses this value with respect to combined IP strategies.

Patent Portfolio Management provides companies with an essential guide to improving the management of their patents. The clear and succinct advice in this book will empower IP and patent departments to audit and structure the patents they own, align the patent portfolio strategy with the business and R&D strategies, and ultimately extract the most value from the patent portfolio to maximise business potential.